Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Clinical trial NCT07458269 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07458269
- Sponsor
- Kailera
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-04
- Primary completion
- 2027-05-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.